Arginine silicate complex and use thereof

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 47/48 (2006.01) A23L 1/304 (2006.01) A23L 1/305 (2006.01) A61K 31/695 (2006.01) A61K 33/00 (2006.01) C07F 7/04 (2006.01)

Patent

CA 2279233

An arginine silicate-containing complex and its use in the prevention and treatment of atherosclerosis, as a dietary supplement and for promotion of structural integrity of bones and joints. The arginine silicate complex is synthesized by combining arginine, potassium silicate and inositol. The complex is administered orally three times per day in an amount ranging from about 250 mg to about 2,500 mg as a preventative or therapeutic agent.

La présente invention concerne un complexe contenant du silicate d'arginine et son utilisation dans la prévention et le traitement de l'athérosclérose, comme complément alimentaire, et dans le but de favoriser l'intégrité structurelle des os et des articulations. Ce complexe silicate d'arginine est synthétisé par combinaison d'arginine, de silicate de potassium et d'inositol. Ce complexe est administré oralement trois fois par jour à raison de 250 mg environ à 2500 mg environ comme agent prophylactique ou thérapeutique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Arginine silicate complex and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Arginine silicate complex and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arginine silicate complex and use thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1555926

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.